Wide Ranks

COO

The Cooper Companies, Inc.

103.43

Top Statistics
Market Cap 20 B Forward PE 25.48 Revenue Growth 7.80 %
Current Ratio 1.99 Trailing PE 57.46 Earnings Growth 20.90 %
Profit Margins 9.45 % Peg Ratio Dividend Yield 0.02 %
Enterprice / EBITA 22.87 Enterprise / Revenue 6.15 Price To Sales Trailing12 Months 5.41
Profitability
Profit Margins 9.45 % Operating Margins 19.20 %
Balance Sheet
Total Cash 109 M Total Cash Per Share 0.5510 Total Debt 2 B
Total Debt To Equity 36.71 Current Ratio 1.99 Book Value Per Share 39.80
All Measures
Short Ratio 176.00 % Message Board Id finmb_263609 Shares Short Prior Month 1 M
Return On Equity 0.0465 City San Ramon Uuid c9cdddf9-eb2c-37dc-810f-f7ed751c0c13
Previous Close 102.64 First Trade Date Epoch Utc 412 M Book Value 39.80
Beta 0.9900 Total Debt 2 B Volume 1 M
Price To Book 2.60 Last Split Date 1 B Fifty Two Week Low 82.22
Total Cash Per Share 0.5510 Total Revenue 3 B Shares Short Previous Month Date 1 B
Target Median Price 115.50 Max Age 86400 Recommendation Mean 1.89
Sand P52 Week Change 0.3133 Operating Margins 19.20 % Last Dividend Value 0.0075
Target Mean Price 114.29 Net Income To Common 359 M Short Percent Of Float 0.0126
Implied Shares Outstanding 199 M Trailing Peg Ratio 1047.55 % Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 109 M
Next Fiscal Year End 1 B Revenue Per Share 19.14 Held Percent Insiders 0.0054
Ebitda Margins 26.89 % Dividend Rate 0.0200 Trailing PE 57.46
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 102.64
Target Low Price 92.12 Gmt Off Set Milliseconds -18000000 Fifty Day Average 105.45
Open 102.16 Dividend Yield 0.02 % State CA
Free Cashflow 148 M Return On Assets 0.0339 Time Zone Short Name EST
Trailing Eps 1.80 Day Low 101.78 Address1 6101 Bollinger Canyon Road
Shares Outstanding 199 M Price Hint 2 Target High Price 130.00
Website https://www.coopercos.com 52 Week Change 0.2279 Average Volume 1 M
Earnings Quarterly Growth 22.70 % Forward Eps 4.08 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 87.50 % Last Split Factor 4:1
Regular Market Day High 103.55 Is_sp_500 True Profit Margins 9.45 %
Debt To Equity 36.71 Fifty Two Week High 112.38 Day High 103.55
Shares Short 2 M Regular Market Open 102.16 Industry Key medical-instruments-supplies
Earnings Growth 20.90 % Enterprise To Revenue 6.15 Revenue Growth 7.80 %
Shares Percent Shares Out 0.0111 Operating Cashflow 615 M Five Year Avg Dividend Yield 2.00 %
Currency USD Market Cap 20 B Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 94583 Quote Type EQUITY
Industry Medical Instruments & Supplies Ex Dividend Date 1 B Regular Market Day Low 101.78
Held Percent Institutions 0.9834 Long Name The Cooper Companies, Inc. Current Price 103.43
Address2 Suite 500 Enterprise To Ebitda 22.87 Financial Currency USD
Current Ratio 1.99 Gross Margins 66.36 % Industry Disp Medical Instruments & Supplies
Number Of Analyst Opinions 14 Country United States Float Shares 197 M
Two Hundred Day Average 97.89 Ir Website http://investor.coopercos.com/ Enterprise Value 23 B
Price To Sales Trailing12 Months 5.41 Forward PE 25.48 Regular Market Volume 1 M
Last Dividend Date 1 B Ebitda 1 B Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.

The company operates in two segments, CooperVision and CooperSurgical.

The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide.

It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing.

The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers.

The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.